Sg. Kamerling et Jg. Owens, MODELS FOR ASSESSING THE RELATIONSHIP BETWEEN DRUG CONCENTRATION AND DRUG EFFECT IN PERFORMANCE HORSES, British Veterinary Journal, 150(6), 1994, pp. 507-525
The actions of most drugs are dependent upon achieving adequate plasma
concentrations. Plasma concentrations are influenced by the degree to
which a drug is absorbed, distributed, metabolized and excreted. Phar
macokinetic assessment reflects changes in these variables as a functi
on of time. Pharmacodynamics refers to specific drug effects or mechan
isms of drug action. Individual drug pharmacokinetics provides informa
tion on which to base a therapeutic dose, route of administration and
dosing interval. However, not all drug actions temporally correlate wi
th plasma kinetics. To resolve this discrepancy, pharmacodynamic model
s of drug action have been developed. In this review several pharmacod
ynamic models of anti-inflammatory and central nervous system effects
are discussed in relationship to individual drug pharmacokinetics in t
he horse. The use of appropriate statistical models can minimize error
and maximize the detection of drug effects over time. Data are presen
ted showing the value of pharmacodynamic models in assessing and predi
cting the onset, peak and duration of drug action. Penetration of drug
s into inflamed tissue or the brain may not temporally correlate with
plasma kinetics. Therefore, drug kinetics in tissues or compartments a
ssociated with a particular effect may be a better predictor of effica
cy than plasma concentrations. Recent studies have shown that exercise
can affect drug disposition and influence both pharmacokinetics and p
harmacodynamics. In competitive athletes, plasma or urine concentratio
ns of drugs are determined to regulate use. Some jurisdictions are adv
ocating the establishment of specific drug thresholds based upon plasm
a or urine concentrations. However, drug effects may occur during low
or undetectable plasma concentrations. Urine concentrations are often
dissociated in time from those in plasma. Therefore, the use of approp
riate pharmacodynamic models, and the exercising horse, can complement
plasma pharmacokinetics in determining drug efficacy and drug thresho
lds.